Peggy Scherle is CSO at Prelude Therapeutics Inc (PRLD). They have made 6 open-market trades across 1 company since 2021, most recently 2021-08-27.
CIK 0001824632
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRLD | 173,527 | $560K |
Shares reported on the most recent Form 4, priced at the 2021-08-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRLD | SELL | 2021-08-26 | 2021-08-30 | $35.78 | $434K | -10.6% | -15.9% | -62.6% |
| PRLD | SELL | 2021-08-13 | 2021-08-17 | $35.07 | $160K | +16.7% | +6.3% | -50.7% |
| PRLD | SELL | 2021-07-27 | 2021-07-29 | $35.47 | $709K | -0.7% | +14.7% | -46.2% |
| PRLD | SELL | 2021-05-07 | 2021-05-11 | $40.81 | $808K | -4.5% | -21.0% | -23.5% |
| PRLD | SELL | 2021-04-08 | 2021-04-15 | $38.35 | $296K | +5.2% | +23.6% | -23.7% |
| PRLD | SELL | 2021-04-07 | 2021-04-09 | $39.30 | $1.2M | +1.5% | +16.4% | -21.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.